Showing results (651-660 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|September 18, 2007
One-compartment model with Michaelis-Menten elimination kinetics and therapeutic window: an analytical approachSanyi Tang, Yanni XiaoJournal of Pharmacokinetics and Pharmacodynamics|December 8, 2006
Mixture modeling for the detection of subpopulations in a pharmacokinetic/pharmacodynamic analysisAnnabelle Lemenuel-Diot, Christian Laveille, Nicolas Frey, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 27, 2005
Grey-box modelling of pharmacokinetic/pharmacodynamic systemsChristoffer W Tornøe, Judith L Jacobsen, Oluf Pedersen, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 26, 2004
Development of a whole body physiologically based model to characterise the pharmacokinetics of benzodiazepines. 1: Estimation of rat tissue-plasma partition ratiosIvelina Gueorguieva, Ivan A Nestorov, Susan Murby, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 11, 2008
Semiparametric mixed-effects analysis of PK/PD models using differential equationsYi Wang, Kent M Eskridge, Shunpu ZhangJournal of Pharmacokinetics and Pharmacodynamics|June 18, 2017
Challenges in longitudinal exposure-response modeling of data from complex study designs: a case study of modeling CDAI score for ustekinumab in patients with Crohn's diseaseChuanpu Hu, Omoniyi J Adedokun, Yang Chen, et al.Journal of Pharmacokinetics and Pharmacodynamics|September 11, 2016
A cell-level model of pharmacodynamics-mediated drug dispositionWojciech Krzyzanski, John M Harrold, Liviawati S Wu, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 26, 2017
Impact of altered endogenous IgG on unspecific mAb clearanceSaskia Fuhrmann, Charlotte Kloft, Wilhelm HuisingaJournal of Pharmacokinetics and Pharmacodynamics|May 9, 2018
Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemiaMita Kuchimanchi, Anita Grover, Maurice G Emery, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 2, 2018
Joint longitudinal model development: application to exposure-response modeling of ACR and DAS scores in rheumatoid arthritis patients treated with sirukumabChuanpu Hu, Yan Xu, Yanli Zhuang, et al.Pageof 107